Learn More
Medchemexpress LLC CCR4-351 | 2174938-70-4 | MFCD32701932 | 99.0% | C24H27Cl2N7O | 10MG

Supplier: Medchemexpress LLC HY13134910MG
CCR4-351 is an orally active, potent, and selective chemokine receptor 4 (CCR4) antagonist for research use. It features a novel piperidinyl-azetidine motif and exhibits low-nanomolar activity in functional assays (reported IC50 ≈ 22 nM in calcium flux and ≈ 50 nM in CTX). The compound has shown antitumor activity in preclinical studies and is supplied at high purity for experimental applications.
- Potent CCR4 antagonist with low-nanomolar activity.
- Selective activity in CCR4 functional assays.
- Demonstrated antitumor activity in preclinical models.
- Suitable for in vitro and in vivo CCR4 pathway research.
- High purity (≈98.95%) for reliable experimental results.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.